• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过敏症登记处:德国过敏症专项登记处的结构、目标群体及主要发现

Registries in allergy: Structure, target groups, and key findings of allergy-focused registries in Germany.

作者信息

Farkic Marie, Globig Philipp, Alexiou Aikaterina, Worm Margitta

机构信息

Division of Allergy and Immunology, Department of Dermatology, Venerology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

出版信息

Allergol Select. 2024 Dec 31;8:425-433. doi: 10.5414/ALX02536E. eCollection 2024.

DOI:10.5414/ALX02536E
PMID:39777267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11706230/
Abstract

In allergology, clinical registries fill knowledge gaps of epidemiology, mechanisms of allergic diseases, and real-world treatment outcomes. Considering the continuous rise of allergic diseases worldwide, registries become increasingly important for the optimization and harmonization of patient care. In the current review, we present four ongoing allergy-focused registries initiated in Germany. We conducted a focused literature search and discussed their structure, main purposes, and findings. Registries included are the "Information Network of Departments of Dermatology", the "European Anaphylaxis Registry", the "GAN Severe Asthma Registry", and "TREATgermany". Despite differences in scope and operation, all registries gather harmonized real-world data that is indispensable for evidence-based decision making in clinical practice and ultimately improves patient care in allergology.

摘要

在过敏医学领域,临床登记系统填补了流行病学、过敏性疾病发病机制及真实世界治疗结果方面的知识空白。鉴于全球过敏性疾病持续增多,登记系统对于优化和统一患者护理变得愈发重要。在本综述中,我们介绍了德国启动的四个正在进行的以过敏为重点的登记系统。我们进行了针对性的文献检索,并讨论了它们的结构、主要目的和研究结果。纳入的登记系统包括“皮肤科部门信息网络”、“欧洲过敏反应登记系统”、“GAN重度哮喘登记系统”和“德国治疗登记系统”。尽管在范围和运作方面存在差异,但所有登记系统都收集了统一的真实世界数据,这些数据对于临床实践中基于证据的决策不可或缺,并最终改善了过敏医学领域的患者护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ad/11706230/d271ec6327c2/allergologieselect-8-425-01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ad/11706230/d271ec6327c2/allergologieselect-8-425-01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ad/11706230/d271ec6327c2/allergologieselect-8-425-01.jpg

相似文献

1
Registries in allergy: Structure, target groups, and key findings of allergy-focused registries in Germany.过敏症登记处:德国过敏症专项登记处的结构、目标群体及主要发现
Allergol Select. 2024 Dec 31;8:425-433. doi: 10.5414/ALX02536E. eCollection 2024.
2
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).IgE介导的过敏性疾病中变应原特异性免疫治疗指南:德国变态反应学与临床免疫学会(DGAKI)、儿科变态反应与环境医学学会(GPA)、德国变态反应科医生医学协会(AeDA)、奥地利变态反应与免疫学会(ÖGAI)、瑞士变态反应与免疫学会(SGAI)、德国皮肤病学会(DDG)、德国耳鼻咽喉头颈外科学会(DGHNO-KHC)、德国儿科学与青少年医学学会(DGKJ)、儿科肺病学会(GPP)、德国呼吸学会(DGP)、德国耳鼻喉外科医生协会(BV-HNO)、儿科医生与青年医生专业联合会(BVKJ)、肺科医生联邦协会(BDP)以及德国皮肤科医生协会(BVDD)的S2k指南
Allergo J Int. 2014;23(8):282-319. doi: 10.1007/s40629-014-0032-2.
3
Overview of registries for anaphylaxis: a scoping review.过敏反应登记处概述:范围综述。
JBI Evid Synth. 2022 Nov 1;20(11):2656-2696. doi: 10.11124/JBIES-21-00182.
4
Improving Clinical Practice Through Patient Registries in Allergy and Immunology.通过过敏与免疫学患者登记改善临床实践。
J Allergy Clin Immunol Pract. 2024 Oct;12(10):2599-2609. doi: 10.1016/j.jaip.2024.05.003. Epub 2024 May 10.
5
Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.成人重度特应性皮炎患者的系统治疗应用和疗效:德国特应性皮炎登记研究 TREATgermany 的初步结果。
J Dtsch Dermatol Ges. 2017 Jan;15(1):49-59. doi: 10.1111/ddg.12958. Epub 2016 Nov 10.
6
Pediatric Allergy: An Overview.儿科过敏:概述。
Prim Care. 2021 Sep;48(3):517-530. doi: 10.1016/j.pop.2021.04.006. Epub 2021 Jul 10.
7
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.全球通用的过敏症修订命名法:世界过敏组织命名法审查委员会报告,2003年10月
J Allergy Clin Immunol. 2004 May;113(5):832-6. doi: 10.1016/j.jaci.2003.12.591.
8
Precision medicine reaching out to the patients in allergology - a German-Japanese workshop report.精准医学在过敏学领域与患者的接触——一份德日研讨会报告
Allergol Select. 2021 May 27;5:162-179. doi: 10.5414/ALX02234E. eCollection 2021.
9
Contact urticaria: Frequency, elicitors and cofactors in three cohorts (Information Network of Departments of Dermatology; Network of Anaphylaxis; and Department of Dermatology, University Hospital Erlangen, Germany).接触性荨麻疹:三个队列中的频率、激发因素和协同因素(德国埃尔朗根大学医院皮肤科信息网络、过敏反应网络和皮肤科)。
Contact Dermatitis. 2019 Nov;81(5):341-353. doi: 10.1111/cod.13331. Epub 2019 Jul 3.
10
TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries.特应性皮炎(TREAT)登记研究工作组:关于如何以及何时测量特应性皮炎治疗研究登记核心数据集的共识。
Br J Dermatol. 2019 Sep;181(3):492-504. doi: 10.1111/bjd.17715. Epub 2019 Jun 23.

本文引用的文献

1
Clinical and molecular response to dupilumab treatment in pediatric atopic dermatitis: Results of the German TREATkids registry.度普利尤单抗治疗儿童特应性皮炎的临床和分子反应:德国TREATkids注册研究结果
Allergy. 2024 Oct;79(10):2849-2852. doi: 10.1111/all.16147. Epub 2024 May 7.
2
Obesity is linked to disease severity in moderate to severe atopic dermatitis-Data from the prospective observational TREATgermany registry.肥胖与中度至重度特应性皮炎的疾病严重程度相关——来自前瞻性观察性TREATgermany注册研究的数据。
J Eur Acad Dermatol Venereol. 2025 Jan;39(1):136-144. doi: 10.1111/jdv.20042. Epub 2024 Apr 25.
3
Treatment of moderate-to-severe atopic dermatitis with baricitinib: Results from an interim analysis of the TREATgermany registry.
巴瑞替尼治疗中重度特应性皮炎:来自德国TREAT注册研究的中期分析结果
J Eur Acad Dermatol Venereol. 2024 Oct;38(10):e887-e891. doi: 10.1111/jdv.19979. Epub 2024 Mar 28.
4
Declining frequency of sensitization to fragrance mixes I and II: IVDK-data of the years 2012-2021.香薰混合物 I 和 II 致敏率的下降:2012-2021 年 IVDK 数据。
Contact Dermatitis. 2024 May;90(5):470-478. doi: 10.1111/cod.14493. Epub 2023 Dec 25.
5
Occupational anaphylaxis-Data from the anaphylaxis registry.职业性过敏反应——过敏登记处的数据。
Allergy. 2024 Mar;79(3):702-710. doi: 10.1111/all.15974. Epub 2023 Dec 13.
6
Real-world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.真实世界中与特应性皮炎患者全身免疫调节治疗相关的不良事件报告:荷兰 TREATNL(特应性皮炎治疗)登记研究结果。
J Eur Acad Dermatol Venereol. 2024 Mar;38(3):530-542. doi: 10.1111/jdv.19643. Epub 2023 Nov 29.
7
Real-life studies and registries of severe asthma: The advent of digital technology.重度哮喘的真实世界研究与注册登记:数字技术的出现
Respir Med. 2023 Dec;220:107429. doi: 10.1016/j.rmed.2023.107429. Epub 2023 Nov 4.
8
Comment on: "Interim results from the PEDISTAD Real-World Registry by Paller et al"-First results from the German TREATkids registry for children and adolescents with moderate-to-severe atopic dermatitis.评论:“帕勒等人的PEDISTAD真实世界注册研究的中期结果”——德国TREATkids注册研究针对中重度特应性皮炎儿童和青少年的首批结果。
J Am Acad Dermatol. 2024 Jan;90(1):e31-e33. doi: 10.1016/j.jaad.2023.08.092. Epub 2023 Sep 17.
9
Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort.成人德国哮喘网络严重哮喘登记处队列中生物制剂治疗的反应和临床缓解。
J Allergy Clin Immunol Pract. 2023 Sep;11(9):2701-2712.e2. doi: 10.1016/j.jaip.2023.05.047. Epub 2023 Jun 8.
10
Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study).德国哮喘网络严重哮喘登记处使用美泊利单抗的真实世界经验(MepoGAN研究)。
J Asthma Allergy. 2023 May 11;16:541-552. doi: 10.2147/JAA.S403286. eCollection 2023.